Winton Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,500
Closed -$500K 1047
2025
Q2
$500K Buy
+18,500
New +$536K 0.03% 596
2024
Q1
Sell
-12,067
Closed -$332K 886
2023
Q4
$332K Sell
12,067
-4,320
-26% -$104K 0.02% 508
2023
Q3
$366K Buy
+16,387
New +$421K 0.03% 471

Other funds holding VCYT

Winton Group's VCYT Position: Q3 2025 in Review

Winton Group sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 18,500 shares — an estimated $500K sold.

Winton Group first reported a position in VCYT in Q3 2023 and held it in 3 quarters. The position peaked at $500K in Q2 2025. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Winton Group reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Winton Group sold 18,500 Veracyte shares in Q3 2025, an estimated $500K.
  • Winton Group first reported a position in Veracyte in Q3 2023 and held it in 3 quarters.
  • Winton Group's Veracyte position peaked at $500K in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.